Drug – bio-affecting and body treating compositions – Identification or warning feature – Taste or smell or chemical irritation to the eye – nose – or...
Patent
1976-07-16
1979-04-03
Fagelson, Anna P.
Drug, bio-affecting and body treating compositions
Identification or warning feature
Taste or smell or chemical irritation to the eye, nose, or...
23230B, 1951035A, 260112R, 424 85, 424 88, 424101, 424177, A23J 106, G01N 3102, G01N 3316
Patent
active
041477650
ABSTRACT:
An antiserum for the quantitative determination of X and Y degradation products of fibrin and fibrinogen is produced by administering the purified degradation products to an experimental animal thereby to immunize said animal, drawing serum from said animal, contacting said serum with a plasma and separating the resultant precipitate, thereby to leave a supernatant liquid which constitutes said antiserum. The plasma may be a heparin, citrate, oxalate, ethylenediaminetetracetate or glutaraldehyde-treated plasma and as many as 12 or 15 precipitations may be made with the animal antiserum. The antiserum may be fractionated at any stage by adsorption on Sephadex modified dextran.
REFERENCES:
Marder, J. Biol. Chem., vol. 244, 1966, pp. 2111-2119.
Fisher, J. Lab. & Clin. Med., vol. 70, 1967, pp. 903-922.
Kotitschke Ronald
Stephan Wolfgang
Biotest-Serum-Institut GmbH
Fagelson Anna P.
LandOfFree
Preparation of antiserum for quantitative determination of X and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparation of antiserum for quantitative determination of X and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation of antiserum for quantitative determination of X and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1746720